Background: Dementia is a known predictor of mortality, but most studies include small numbers of participants above age 90. The influence of dementia or cognition on mortality in this age group is therefore uncertain.
Life expectancy has increased worldwide and the proportion of the population above age 90 has increased dramatically. For example, the number of Swedish 90-year-olds and above increased from 9,000 in 1960 to 70,000 in 2003. 1 Dementia influences life expectancy according to several studies. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In a Chinese population, the contribution of dementia to 5-year mortality increased from about 5% at ages 65 to 74 to almost 24% among individuals aged 75 years or older. 3 In a population study from Göteborg, Sweden, the contribution of dementia to 7-year mortality was 31% for men and 50% for women at age 85. 11 Both Alzheimer disease (AD) and vascular dementia (VaD) were found to influence the mortality rate. Furthermore, in a population-based study from Utah, 12 including approximately 5,000 elderly subjects age 65 and above, the population attributable risk (PAR) of death predicted by dementia was 27%. In this sample PAR was two to three times higher for dementia than for any other illness studied. Most of these studies include small numbers of participants above age 90, where both dementia prevalence and mortality are high. The influence of dementia on mortality in this age group is therefore uncertain.
We recently reported that the prevalence of dementia increases from 30% in 85-yearolds to 50% in 95-year-olds. 13 To clarify the relationship between dementia and mortality among the oldest old, we examined the influence of dementia on mortality in this population-based sample of 338 95-year-olds in Göteborg, Sweden. 13 In addition, we examined the relationship between mortality and cognitive function using the Mini-Mental State Examination (MMSE) in 95year-olds without dementia.
METHODS Participants. This analysis includes 95-yearold participants from the Göteborg 95ϩ Study. All 95-yearolds living in Göteborg, Sweden, and born between July 1, 1901, and December 31, 1903, were selected to participate in a health survey. Names and addresses were obtained from the Swedish Population Register (n ϭ 589). Of those, 3 individuals were excluded due to non-Swedish language, 18 could not be traced, and 47 died before they could be contacted, leaving 521 available individuals. Among those, 338 (263 women and 75 men) agreed to participate (response rate 65%). The sample has been described in detail previously, 13 and was similar to its population base regarding mortality and marital status.
The MMSE was done in 335 (99%) of the participants, and complete MMSE in 263 (78%). The analyses of MMSE in relation to mortality in this article were only assessed among the subjects without dementia. In these analyses, the sample comprised 164 individuals. Of those, 161 performed MMSE. In order to have a clean measure, we decided to include only those with complete tests (n ϭ 133; 81% of the target sample).
The Ethics Committee at Göteborg University approved the study. All participants gave their written informed consent. In those with dementia, where informed consent could not be obtained, consent was obtained from a close relative.
Examinations. All participants were examined by trained psychiatrists. The examination included a semi-structured examination including the Comprehensive Psychopathological Rating Scale (CPRS) 14 and assessment of cognitive function (e.g., rating of recent and remote memory; orientation for time, place, person, and situation; knowledge of general information; motor apraxia; constructional apraxia; ide-ational apraxia; ability to understand proverbs; ability to follow commands; finger naming; naming ability; and rating of spoken language). Cognitive function was further assessed using the Swedish version of the MMSE, with a maximum score of 30. 15 Activities of daily living (ADL) were assessed using the Gottfries-Bråne-Steen Scale, 16 which measures intellectual and emotional functioning, as well as independence in dressing, eating, personal hygiene, and control of bladder and bowel. A brief physical examination, including standardized blood pressure measurements and assessment of neurologic signs and symptoms, was also completed by a physician.
Close informant interviews. Close informant interviews
were conducted by trained nurses for 283 (84%) of the participants, and included questions about changes in behavior and intellectual function (e.g., personality, memory, visuospatial functions, intellectual ability, language, psychiatric symptoms), ADL (handling money, using telephone, preparing food, dressing, personal hygiene, eating, incontinence), history of medical conditions, and, in cases of dementia, questions about age at onset and course.
Diagnosis of dementia.
Dementia and its severity (mild, moderate, or severe) were diagnosed using combined information from the examinations in the participant's home and the close informant interviews, based on the criteria of the Diagnostic and Statistical Manual of Mental Disorders (third edition, revised; DSM-III-R). 17 All information was evaluated independently by two psychiatrists, who after diagnosing dementia assigned a severity level. In cases of disagreement, a consensus conference was held. For mild dementia, an individual manages to live independently (e.g., forgets meetings and to pay bills, cannot shop independently). Moderate dementia is diagnosed when there is a need for daily assistance (e.g., cannot cook independently, some help with hygiene and dressing). Severe dementia is diagnosed when continuous supervision and care are needed (e.g., bedridden, severe fecal and urinary incontinence, total help with hygiene and dressing, cannot eat independently, severe language disturbance).
The diagnostic criteria for AD were based on the National Institute of Neurological and Communicative Disorders and Stroke and the AD and Related Disorders Association, 18 disregarding the 90-year age limit. VaD was diagnosed similar to the National Institute of Neurological Disorders and Stroke and the Association Internationale pour la Recherce et l'Enseignement en Neurosciences. 19 Probable VaD was diagnosed when there was temporal relationship (within 1 year) between stroke symptoms and dementia onset, and possible VaD (which includes mixed dementia) in other cases with stroke and dementia.
Dementia diagnoses were based on all sources of information. As previously reported, 13 174 (146 women, 28 men) 95-year-olds had dementia: 119 probable or possible AD and 53 probable or possible VaD. Of all dementias, mild dementia was classified among 5.2% (n ϭ 9), moderate dementia among 48.6% (n ϭ 85), and severe dementia among 46.0% (n ϭ 80).
Other diagnoses. Diagnoses of physical disorders were obtained from the Swedish Hospital Discharge Register, which covers all diagnosis of patients discharged from Swedish hospitals since 1980. In Sweden, it is mandatory that doctors register primary and secondary diagnosis according to the International Classification of Diseases on all patients discharged from hospitals. The primary diagnosis is the main cause for hospitalization, and secondary diagnoses include all other diagnoses that the patient might have. Among all participants, 91% were registered for at least one diagnosis during this period and there was no difference between men (90.7%) and women (91.3%; p ϭ 0.40), or between those diagnosed with dementia (93.7%) and the subjects without dementia (88.4%; p ϭ 0.21). Institutionalized individuals were more often registered than non-institutionalized individuals (94.8% vs 86.4%; p ϭ 0.01). The following common medical conditions were selected: diabetes mellitus, angina pectoris (AP), myocardial infarction (MI), congestive heart failure (CHF), atrial fibrillation (AF), stroke, chronic obstructive pulmonary disease (COPD), hip fracture, and cancer (all types). Depression was diagnosed according to DSM-III-R, 17 based on the examination at age 95.
Dates of death were obtained from the Swedish Population Register, which is a national register containing all individuals living in Sweden and Swedish citizens living abroad. According to Swedish law, a death certificate signed by a physician has to be sent to the authorities (i.e., this register) before any funeral ceremonies can take place. This register is known to be complete regarding mortality data.
Statistical analyses. Differences in proportions were evaluated using Fisher exact test or Pearson 2 (using two-tailed tests). Means (SD) were calculated for continuous variables and t tests were used to test for differences. Binomial CIs (95% CI) were calculated for frequencies, medians, and relative risks (RR).
Cox regression analyses were used to calculate the RR for factors related to death within 5 years. Time at risk was calculated from the date of examination at age 95 to death or 5 years for survivors. Univariate regression analyses were used to evaluate the following potential predictors of death: gender, dementia, depression, diabetes mellitus, stroke, COPD, hip fracture, cancer (all types), AP, MI, AF, and CHF.
Variables were included in multivariate regression models, if they met the criteria of p Յ 0.10 in univariate analyses with adjustment for gender. In order to avoid overlapping diagnoses in the multivariate analyses we used a combined variable for cardiac diseases, including AP, MI, AF, and CHF.
The population attributable risk (PAR) for various disorders contributing to overall mortality in this sample was also calculated. The PAR takes into consideration both the RR of death in individuals with the disorder and the prevalence of the disorder in the population. PAR was calculated according to the following formula:
where p is the proportion of the population with the risk factor and r is the relative risk. 20 Finally, we examined the effect of cognitive function on mortality in 95-year-olds without dementia, using the MMSE in Cox regression analyses controlling for potential confounders as described above.
RESULTS
Of the 338 95-year-olds participating at baseline, 51 individuals (15.1%) were still alive 5 years later. The proportion of those surviving was similar in men (n ϭ 10, 13.3%) and women (n ϭ 41, 15.6%; p ϭ 0.72). The median survival time was 2.1 years (95% CI 1.9 to 2.4) for all 95year-olds (2.0 years in men and 2.2 years in women) (table 1). Participants and nonparticipants at age 95 had similar mortality proportions (3-year mortality: 61.2% vs 60.2%, p ϭ 0.85; 5-year mortality: 84.6% vs 86.0%, p ϭ 0.72).
Five-year mortality was 73.2% (n ϭ 120/164) among the subjects without dementia, and 96.0% (n ϭ 167/174) among 95-year-olds with dementia (p Ͻ 0.0001). There was no difference in 5-year mortality between men and women (figure 1), neither among the subjects without dementia (men 78.7% [n ϭ 37/47] vs women 70.1% [n ϭ 82/117]; p ϭ 0.33) nor among those with dementia (men 100% [n ϭ 28/28] vs women 95.2% [n ϭ 139/146]; p ϭ 0.60). We could not confirm any difference in mortality between AD and VaD cases (table 1) .
Those with mild dementia had a lower 3-year mortality than those with moderate or severe dementia (56% vs 78%; p ϭ 0.035), while there was no difference in 5-year mortality between the groups (figure 2). The median survival time was 3.1 years (95% CI 2.6 to 3.5) among the subjects without dementia, 2.9 years (95% CI 0.7 to 4.1) in those with mild dementia, 1.5 years (95% CI 1.2 to 2.0) in those with moderate dementia, and 1.4 years (95% CI 1.0 to 1.9) in those with severe dementia (table 1) . Results of univariate analyses regarding the influence of different medical conditions on mortality are given in table 2. Male sex, dementia, cardiac diseases, cancer, and stroke met the criteria of a p value Յ 0.10 for inclusion in multivariate analyses, where male sex, dementia, cardiac disease, and cancer were independent predictors of 5-year mortality rate (table 3) .
The PAR for death due to dementia, controlling for other contributors to death, was considerably higher than for the other diagnoses, and higher in women than in men (44% vs 30%). The PAR for death predicted by cancer was higher in men than in women (18% vs 3%).
We then evaluated the influence of cognitive function, measured using the MMSE, on mortality in the subjects without dementia. Of the 161 out of 164 subjects without dementia who performed the MMSE, 17.4% (n ϭ 28) were not able to perform all items on the test due to physical or sensory impairments, and were excluded from further analyses. Thus, 133 persons (81% of the subjects without dementia) were included in this analysis. There was an association between MMSE score at baseline and mortality in 95-yearolds without dementia. Mean MMSE score at baseline was higher in subjects without dementia who survived to age 100 than in those who died (27.1 [SD 3.1] vs 25.0 [SD 3.9]; p ϭ 0.001). In a multivariate Cox regression model adjusting for gender, cardiac disease, previous stroke, cancer, and current depression, we found that for each point increase in MMSE score, mortality decreased by 13% (RR 0.87, 95% CI 0.81 to 0.94; p Ͻ 0.0002). DISCUSSION We found that dementia strongly affected mortality in 95-year-olds. Only 4% of 95year-olds with dementia reached the age of 100 years compared with 27% of the subjects without dementia. When controlling for other severe medical conditions we found dementia to be the leading cause of deaths among the oldest old. Dementia predicted 44% of all deaths in women and 30% in men, which was considerably higher than for any other medical diagnosis. Furthermore, among those without dementia, mortality was related to cognitive performance, and decreased by 13% for each point increase in a cognitive test, the MMSE. Our findings are similar to those reported in younger age groups. 3, 11, 12, 21, 22 It is not clear why dementia and low cognitive performance increase mortality. There are some possible explanations. First, cognitive dysfunction, including dementia and AD, may indicate a general reduction in overall vitality. Second, as the brain regulates homeostasis, e.g., blood pressure, temperature, appetite, and levels of a variety of hormones, different brain pathologies, such as AD and other dementing disorders, may therefore cause dysregulation of these functions as is evidenced by declines in blood pressure 23 and body mass index 21, 24 in preclinical and clinical stages of AD. This dysregulation may potentially increase mortality. Third, physical disorders may be neglected among individuals with dementia, leading to mortality.
Figure 1
Five-year survival (%) after age 95 (numbers at baseline were 75 men and 263 women)
Figure 2
Five-year survival (%) after age 95 in relation to severity of dementia at baseline (numbers at baseline: no dementia n ϭ 164; mild dementia n ϭ 9; moderate dementia n ϭ 85; severe dementia n ϭ 80)
Most studies report higher mortality in men compared to women. 11 We found that 5-year mortality was similar among 95-year-old men and women, although women had a higher prevalence of dementia, 13 and when controlling for dementia, male sex was a predictor of mortality. Regarding other disorders, men had a higher prevalence than women of previous or current cancer which was related to mortality in men but not in women.
The frequency of previous stroke was similar in men and women (13% vs 14%). It is noteworthy that history of stroke did not predict mortality in this very old sample, in contrast to a previous report on 85-year-olds where previous stroke increased mortality in women but not in men, 11 and studies of younger age groups where stroke increased mortality in both men and women. 25 This might explain why mortality was similar in AD and VaD in our study, in contrast to most other studies where VaD has a higher mortality rate than AD. 11 Some limitations of the study need to be discussed. First, we obtained the information on physical disorders (cardiac diseases, cancer, and stroke) from the Swedish Hospital Discharge Register, and not from direct examinations. The use of the Hospital Discharge Register likely underestimates the frequency of physical disorders, since only those admitted to a hospital are registered. On the other hand, the use of the register might overestimate the relation of these disorders to mortality due to more severe disorders or due to comorbid medical conditions. The finding that 91% of the participants were registered in the Hospital Discharge Register suggests that this bias did not influence the results substantially. Furthermore, one might believe that persons with dementia and patients living in nursing homes should be less likely to be referred to hospitals. In this survey we found that individuals with dementia were registered to the same extent as other 95year-olds, while institutionalized individuals were registered more often. The latter finding indicates that the non-institutionalized individuals were healthier than the institutionalized, but it is not likely that the difference would have a major impact on the results obtained in this study.
Second, only 65% of those contacted agreed to participate in the study. However, this might be regarded as a fairly good response rate for this age group and the equal rate of mortality between responders and nonresponders suggests that the groups were similar.
Third, the number of persons in some of the subgroups, such as mild dementia, was small, which means that results in these groups should be interpreted cautiously.
Finally, the MMSE is a rather crude measure of cognitive function. This should have decreased the possibility of finding associations between MMSE score and mortality in the group without dementia. We believe that the findings in this study are sufficiently robust that they are unlikely to be the result of any of these possible sources of error. In an era where the number of people reaching extreme old age increases dramatically, our study sheds light on factors related to survival in this age group.
